Genetics for personalized coronary heart disease treatmentNovember 12, 2008Identifying a single, common variation in a person's genetic information improves prediction of his or her risk of a heart attack or other heart disease events and thus, choice of the best treatment accordingly, said researchers at Baylor College of Medicine in Houston. These findings are being presented today at the American Heart Association's Scientific Sessions in New Orleans. "This DNA variation at 9p21 chromosomal region is not a mutation; it is a genetic variant," said Ariel Brautbar, clinical postdoctoral fellow in molecular and human genetics at BCM and lead author of the study, which is one of the presentations designated "Best of Sessions" at the annual American Heart Association meeting.
"We already know that 9p21 DNA variation is associated with a greater risk of heart events, but now we have shown its direct usefulness to patient care by adding it to traditional risk factor measurements," he said. "This is done in order to establish better prediction of a person's risk for coronary heart disease and make appropriate changes in their treatment." Brautbar and the Atherosclerosis Risk in Communities researchers followed 10,000 people already taking part in this large study of middle-aged Americans designed to investigate the causes and natural history of atherosclerosis. Participants were already categorized, based on traditional risk factors, as low, intermediate, or high risk for heart disease events. Low risk was defined as having a less than 10 percent chance of having coronary heart disease in the next 10 years. People with a 10 percent to 20 percent chance in the next decade were considered intermediate risk. Anyone with a risk of 20 percent or greater is considered high risk. However, some people in the 5 percent to 10 percent risk range seem to have more than "low risk." In Brautbar's study, many of those who have the genetic variation at 9p21 had a higher risk than previously thought. Nearly 20 percent in the 5 percent to 10 percent (low risk) range, and more than 16 percent in the 10 percent to 20 percent (intermediate risk) range had to be recategorized. "It significantly improved our risk prediction," said Christie Ballantyne, chief of atherosclerosis and vascular medicine and professor of medicine at BCM. "Since many people's risk categories changed, the optimal treatment for these individuals had to be reevaluated." Those already at intermediate risk were most affected by these results, Brautbar added. "A person at high risk will be treated aggressively, regardless of whether he or she has this variation. A low-risk person with good health won't be treated differently either," he said. "However, someone in the intermediate risk group could be moved into a higher or lower risk category, depending on whether he or she has the genetic variant. This, in turn, could affect how he or she is treated." The test to identify whether there is a variation at 9p21 involves taking blood or swabbing the inside of a person's cheek to obtain DNA. "This study shows us that each person's particular genetic information may play a role in personalizing preventative treatment for that individual," Brautbar said. Baylor College of Medicine Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Asteroids Eating Disorders Cardiovascular Disease Statin Therapy Venus Express Atomic Clock Nevirapine Magnetic Field Fatigue Helicobacter pylori Wind Power Immune Cell Lead Exposure Metformin Bison Wetlands Abdominal Pain Autoimmune Disease Fingerprints Carbon Dioxide Childhood Cancer Cosmic Dust Food Poisoning Superconductors Agriculture
See More: Science News Tags | |||||||||||||||||||||
|
Related Heart Disease Current Events and Heart Disease News Articles Lack of sleep could be more dangerous for women than men Women who get less than the recommended eight hours sleep a night are at higher risk of heart disease and heart-related problems than men with the same sleeping patterns. ADA releases updated position paper on vegetarian diets The American Dietetic Association has released an updated position paper on vegetarian diets that concludes such diets, if well-planned, are healthful and nutritious for adults, infants, children and adolescents and can help prevent and treat chronic diseases including heart disease, cancer, obesity and diabetes. Sleep duration is associated with variations in levels of inflammatory markers in women A study in the July 1 issue of the journal SLEEP demonstrates that levels of inflammatory markers varied significantly with self-reported sleep duration in women but not men. New tool finds best heart disease and stroke treatments for patients with diabetes Researchers from North Carolina State University and Mayo Clinic have developed a computer model that medical doctors can use to determine the best time to begin using statin therapy in diabetes patients to help prevent heart disease and stroke. Polycystic ovarian syndrome: New light on its causes and its effect on brothers Researchers have found evidence that chronic disease in either a mother or father can create unfavourable conditions in the womb that are associated with the development of polycystic ovarian syndrome (PCOS) in daughters. Longer life linked to specific foods in Mediterranean diet Some food groups in the Mediterranean diet are more important than others in promoting health and longer life. New therapy found to prevent heart failure A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) versus patients who received only an implanted cardiac defibrillator (ICD-only). Bypass surgery has long-term benefits for children with Kawasaki disease Coronary artery bypass surgery provides long-term benefits for children whose hearts and blood vessels are damaged by Kawasaki disease, Japanese researchers report in Circulation: Journal of the American Heart Association. More patients across the world lowering 'bad' cholesterol The percentage of patients lowering their elevated "bad" cholesterol to within target levels nearly doubled in the last decade, according to a multi-national survey reported in Circulation: Journal of the American Heart Association. Atrial fibrillation in endurance athletes still poses problems for sports cardiologists The fulfilment which so many people increasingly derive from competitive sports and endurance training comes with a real - even if rare - twist. More Heart Disease Current Events and Heart Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||